US Patent Issued to Regeneron Pharmaceuticals on Feb. 4 for "IgG Fc-IL2-RAlpha-IL2 fusions and methods of use thereof" (New York Inventors)

ALEXANDRIA, Va., Feb. 5 -- United States Patent no. 12,215,131, issued on Feb. 4, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"IgG Fc-IL2-RAlpha-IL2 fusions and methods of use thereof" was invented by Jiaxi Wu (Elmsford, N.Y.), Tong Zhang (New Rochelle, N.Y.), Maria del Pilar Molina-Portela (Bronx, N.Y.), Eric Smith (New York), Chia-Yang Lin (Scarsdale, N.Y.) and Thomas Craig Meagher (Yorktown Heights, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to IL2 agonists with improved therapeutic profiles."

The patent was filed on May 9, 2023, under Application No. 18/314,205.

*For further information, including images, charts and tables, please visit: htt...